SCHEMBL21101762

SCHEMBL21101762

CCC(=O)Nc1cc(S(C)(=O)=O)ccc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
MAPT P10636 2/20 0.55
ATM Q13315 1/20 0.49
MAPK14 Q16539 1/20 0.47
POLB P06746 3/20 0.47
MEN1 O00255 1/20 0.47
APOBEC3A P31941 1/20 0.47
RECQL P46063 1/20 0.47
KMT2A Q03164 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HTT P42858 1/20 0.47
GAA P10253 3/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6343224 0.86 ALDH1A1 (0.74) ALDH1A1MAPTPOLBHTTGAA
SCHEMBL21102719 0.86 POLB (0.63) ALDH1A1MAPTPOLBHTTCA12
SCHEMBL21101766 0.85 BRD4 (0.55) ALDH1A1MAPTATMPOLBMEN1
SCHEMBL30098959 0.81 ALDH1A1 (0.51) ALDH1A1MAPTATMPOLBMEN1
SCHEMBL13752250 0.78 HDAC3 (0.64) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL21102206 0.78 ALDH1A1 (0.51) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL26188045 0.77 ALDH1A1 (0.57) ALDH1A1MAPTMEN1KMT2AHTT
SCHEMBL23591991 0.77 TGM2 (0.60) ALDH1A1MAPTMAPK14POLBRECQL
SCHEMBL12971593 0.77 POLB (0.58) ALDH1A1MAPTATMPOLBMEN1
SCHEMBL21902832 0.76 NPC1 (0.52) ALDH1A1MAPTPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 WO disclosed